Sonoma Pharmaceuticals
SNOA
#10401
Rank
C$8.62 M
Marketcap
C$5.07
Share price
-3.44%
Change (1 day)
36.34%
Change (1 year)

Earnings for Sonoma Pharmaceuticals (SNOA)

Earnings in 2025 (TTM): -C$4.39 Million

According to Sonoma Pharmaceuticals's latest financial reports the company's current earnings are C$16.93 Million. In 2024 the company made an earning of -C$6.2 Million a decrease over its 2023 earnings that were of -C$6.17 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sonoma Pharmaceuticals from 2005 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$4.39 Million-29.31%
2024 -C$6.2 Million0.54%
2023 -C$6.17 Million-31.5%
2022 -C$9.01 Million16.86%
2021 -C$7.71 Million194.32%
2020 -C$2.62 Million-58.76%
2019 -C$6.35 Million-65.66%
2018 -C$18.49 Million4.84%
2017 -C$17.63 Million-2.17%
2016 -C$18.03 Million32.12%
2015 -C$13.64 Million-307.74%
2014 C$6.56 M-197.5%
2013 -C$6.74 Million
2010 -C$10.53 Million-14.02%
2009 -C$12.24 Million-57.28%
2008 -C$28.65 Million-8.03%
2007 -C$31.15 Million3.85%
2006 -C$29.99 Million39.31%
2005 -C$21.53 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Onconova Therapeutics
ONTX
-C$25.23 Million 482.11%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
-C$0.23 Billion 5,013.15%๐Ÿ‡บ๐Ÿ‡ธ USA